 | • レポートコード：QYR9N7250 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、糖鎖生物学（診断と治療学）のグローバル市場について調査・分析したレポートで、種類別（診断、治療学）、用途別（診療所、病院、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・糖鎖生物学（診断と治療学）の世界市場規模 ・主要企業別市場シェア ・糖鎖生物学（診断と治療学）の世界市場規模：種類別（診断、治療学） ・糖鎖生物学（診断と治療学）の世界市場規模：用途別（診療所、病院、その他） ・糖鎖生物学（診断と治療学）のアメリカ市場規模（種類別、用途別） ・糖鎖生物学（診断と治療学）のヨーロッパ市場規模（種類別、用途別） ・糖鎖生物学（診断と治療学）の中国市場規模（種類別、用途別） ・糖鎖生物学（診断と治療学）の日本市場規模（種類別、用途別） ・糖鎖生物学（診断と治療学）の東南アジア市場規模（種類別、用途別） ・糖鎖生物学（診断と治療学）のインド市場規模（種類別、用途別） ・糖鎖生物学（診断と治療学）の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・糖鎖生物学（診断と治療学）の世界市場予測（2019年-2025年） ・糖鎖生物学（診断と治療学）の地域別市場予測（2019年-2025年） ... |
Glycobiology is the study of the structure, biosynthesis, and biology of saccharides that are widely distributed in nature. Glycobiology is the study of the structure, function and biology of carbohydrates, also called glycans. Glycans are present in every living organism. Glycobiology is a rapidly growing field in biology, with relevance to biomedicine, biotechnology and basic research.Glycans are diverse, complex molecules and their functions are determined by their unique structures. Effective enzymatic tools and analytical techniques are required to properly elucidate glycan structure, which can then be correlated to a specific function.
Glycosylation defines the adhesive properties of proteins and cells. The immune system largely functions via glycan-protein interactions, which highlights the importance of glycans in physiology, pathogen recognition, cancer and autoimmune diseases.
Glycan molecules modulate many other processes important for cell and tissue differentiation, metabolic and gene regulation, protein activity, protein clearance, transport and more.
In 2018, the global Glycobiology (Diagnostics and Therapeutics) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Glycobiology (Diagnostics and Therapeutics) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Glycobiology (Diagnostics and Therapeutics) development in United States, Europe and China.
The key players covered in this study
Biomarin Pharmaceutical Inc.
Glycomimetics
Glycan Biosciences Llc
Glycosensors And Diagnostics Llc
Glycotest Inc.
…
Market segment by Type, the product can be split into
Diagnostics
Therapeutics
Market segment by Application, split into
Clinic
Hospital
Other
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Glycobiology (Diagnostics and Therapeutics) status, future forecast, growth opportunity, key market and key players.
To present the Glycobiology (Diagnostics and Therapeutics) development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Glycobiology (Diagnostics and Therapeutics) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Glycobiology (Diagnostics and Therapeutics) Market Size Growth Rate by Type (2014-2025)
1.4.2 Diagnostics
1.4.3 Therapeutics
1.5 Market by Application
1.5.1 Global Glycobiology (Diagnostics and Therapeutics) Market Share by Application (2014-2025)
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Glycobiology (Diagnostics and Therapeutics) Market Size
2.2 Glycobiology (Diagnostics and Therapeutics) Growth Trends by Regions
2.2.1 Glycobiology (Diagnostics and Therapeutics) Market Size by Regions (2014-2025)
2.2.2 Glycobiology (Diagnostics and Therapeutics) Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Glycobiology (Diagnostics and Therapeutics) Market Size by Manufacturers
3.1.1 Global Glycobiology (Diagnostics and Therapeutics) Revenue by Manufacturers (2014-2019)
3.1.2 Global Glycobiology (Diagnostics and Therapeutics) Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Glycobiology (Diagnostics and Therapeutics) Market Concentration Ratio (CR5 and HHI)
3.2 Glycobiology (Diagnostics and Therapeutics) Key Players Head office and Area Served
3.3 Key Players Glycobiology (Diagnostics and Therapeutics) Product/Solution/Service
3.4 Date of Enter into Glycobiology (Diagnostics and Therapeutics) Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Glycobiology (Diagnostics and Therapeutics) Market Size by Type (2014-2019)
4.2 Global Glycobiology (Diagnostics and Therapeutics) Market Size by Application (2014-2019)
5 United States
5.1 United States Glycobiology (Diagnostics and Therapeutics) Market Size (2014-2019)
5.2 Glycobiology (Diagnostics and Therapeutics) Key Players in United States
5.3 United States Glycobiology (Diagnostics and Therapeutics) Market Size by Type
5.4 United States Glycobiology (Diagnostics and Therapeutics) Market Size by Application
6 Europe
6.1 Europe Glycobiology (Diagnostics and Therapeutics) Market Size (2014-2019)
6.2 Glycobiology (Diagnostics and Therapeutics) Key Players in Europe
6.3 Europe Glycobiology (Diagnostics and Therapeutics) Market Size by Type
6.4 Europe Glycobiology (Diagnostics and Therapeutics) Market Size by Application
7 China
7.1 China Glycobiology (Diagnostics and Therapeutics) Market Size (2014-2019)
7.2 Glycobiology (Diagnostics and Therapeutics) Key Players in China
7.3 China Glycobiology (Diagnostics and Therapeutics) Market Size by Type
7.4 China Glycobiology (Diagnostics and Therapeutics) Market Size by Application
8 Japan
8.1 Japan Glycobiology (Diagnostics and Therapeutics) Market Size (2014-2019)
8.2 Glycobiology (Diagnostics and Therapeutics) Key Players in Japan
8.3 Japan Glycobiology (Diagnostics and Therapeutics) Market Size by Type
8.4 Japan Glycobiology (Diagnostics and Therapeutics) Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Glycobiology (Diagnostics and Therapeutics) Market Size (2014-2019)
9.2 Glycobiology (Diagnostics and Therapeutics) Key Players in Southeast Asia
9.3 Southeast Asia Glycobiology (Diagnostics and Therapeutics) Market Size by Type
9.4 Southeast Asia Glycobiology (Diagnostics and Therapeutics) Market Size by Application
10 India
10.1 India Glycobiology (Diagnostics and Therapeutics) Market Size (2014-2019)
10.2 Glycobiology (Diagnostics and Therapeutics) Key Players in India
10.3 India Glycobiology (Diagnostics and Therapeutics) Market Size by Type
10.4 India Glycobiology (Diagnostics and Therapeutics) Market Size by Application
11 Central & South America
11.1 Central & South America Glycobiology (Diagnostics and Therapeutics) Market Size (2014-2019)
11.2 Glycobiology (Diagnostics and Therapeutics) Key Players in Central & South America
11.3 Central & South America Glycobiology (Diagnostics and Therapeutics) Market Size by Type
11.4 Central & South America Glycobiology (Diagnostics and Therapeutics) Market Size by Application
12 International Players Profiles
12.1 Biomarin Pharmaceutical Inc.
12.1.1 Biomarin Pharmaceutical Inc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Glycobiology (Diagnostics and Therapeutics) Introduction
12.1.4 Biomarin Pharmaceutical Inc. Revenue in Glycobiology (Diagnostics and Therapeutics) Business (2014-2019)
12.1.5 Biomarin Pharmaceutical Inc. Recent Development
12.2 Glycomimetics
12.2.1 Glycomimetics Company Details
12.2.2 Company Description and Business Overview
12.2.3 Glycobiology (Diagnostics and Therapeutics) Introduction
12.2.4 Glycomimetics Revenue in Glycobiology (Diagnostics and Therapeutics) Business (2014-2019)
12.2.5 Glycomimetics Recent Development
12.3 Glycan Biosciences Llc
12.3.1 Glycan Biosciences Llc Company Details
12.3.2 Company Description and Business Overview
12.3.3 Glycobiology (Diagnostics and Therapeutics) Introduction
12.3.4 Glycan Biosciences Llc Revenue in Glycobiology (Diagnostics and Therapeutics) Business (2014-2019)
12.3.5 Glycan Biosciences Llc Recent Development
12.4 Glycosensors And Diagnostics Llc
12.4.1 Glycosensors And Diagnostics Llc Company Details
12.4.2 Company Description and Business Overview
12.4.3 Glycobiology (Diagnostics and Therapeutics) Introduction
12.4.4 Glycosensors And Diagnostics Llc Revenue in Glycobiology (Diagnostics and Therapeutics) Business (2014-2019)
12.4.5 Glycosensors And Diagnostics Llc Recent Development
12.5 Glycotest Inc.
12.5.1 Glycotest Inc. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Glycobiology (Diagnostics and Therapeutics) Introduction
12.5.4 Glycotest Inc. Revenue in Glycobiology (Diagnostics and Therapeutics) Business (2014-2019)
12.5.5 Glycotest Inc. Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
Table Glycobiology (Diagnostics and Therapeutics) Key Market Segments
Table Key Players Glycobiology (Diagnostics and Therapeutics) Covered
Table Global Glycobiology (Diagnostics and Therapeutics) Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Glycobiology (Diagnostics and Therapeutics) Market Size Market Share by Type 2014-2025
Figure Diagnostics Figures
Table Key Players of Diagnostics
Figure Therapeutics Figures
Table Key Players of Therapeutics
Table Global Glycobiology (Diagnostics and Therapeutics) Market Size Growth by Application 2014-2025 (Million US$)
Figure Clinic Case Studies
Figure Hospital Case Studies
Figure Other Case Studies
Figure Glycobiology (Diagnostics and Therapeutics) Report Years Considered
Table Global Glycobiology (Diagnostics and Therapeutics) Market Size 2014-2025 (Million US$)
Figure Global Glycobiology (Diagnostics and Therapeutics) Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Glycobiology (Diagnostics and Therapeutics) Market Size by Regions 2014-2025 (Million US$)
Table Global Glycobiology (Diagnostics and Therapeutics) Market Size by Regions 2014-2019 (Million US$)
Table Global Glycobiology (Diagnostics and Therapeutics) Market Share by Regions 2014-2019
Figure Global Glycobiology (Diagnostics and Therapeutics) Market Share by Regions 2014-2019
Figure Global Glycobiology (Diagnostics and Therapeutics) Market Share by Regions 2019
Table Market Top Trends
Table Global Glycobiology (Diagnostics and Therapeutics) Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Glycobiology (Diagnostics and Therapeutics) Market Share by Manufacturers (2014-2019)
Figure Global Glycobiology (Diagnostics and Therapeutics) Market Share by Manufacturers in 2018
Table Global Glycobiology (Diagnostics and Therapeutics) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Glycobiology (Diagnostics and Therapeutics) Product/Solution/Service
Table Date of Enter into Glycobiology (Diagnostics and Therapeutics) Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Glycobiology (Diagnostics and Therapeutics) Market Size by Type (2014-2019) (Million US$)
Table Global Glycobiology (Diagnostics and Therapeutics) Market Size Share by Type (2014-2019)
Figure Global Glycobiology (Diagnostics and Therapeutics) Market Size Market Share by Type (2014-2019)
Table Global Glycobiology (Diagnostics and Therapeutics) Market Size by Application (2014-2019) (Million US$)
Table Global Glycobiology (Diagnostics and Therapeutics) Market Size Share by Application (2014-2019)
Figure Global Glycobiology (Diagnostics and Therapeutics) Market Size Market Share by Application (2014-2019)
Figure Global Glycobiology (Diagnostics and Therapeutics) Revenue Market Share by Application in 2018
Figure United States Glycobiology (Diagnostics and Therapeutics) Market Size 2014-2019 (Million US$)
Table United States Key Players Glycobiology (Diagnostics and Therapeutics) Revenue (2018-2019) (Million US$)
Table United States Key Players Glycobiology (Diagnostics and Therapeutics) Market Share (2018-2019)
Table United States Glycobiology (Diagnostics and Therapeutics) Market Size by Type (2014-2019) (Million US$)
Table United States Glycobiology (Diagnostics and Therapeutics) Market Share by Type (2014-2019)
Table Europe Key Players Glycobiology (Diagnostics and Therapeutics) Revenue (2018-2019) (Million US$)
Table Europe Key Players Glycobiology (Diagnostics and Therapeutics) Market Share (2018-2019)
Table Europe Glycobiology (Diagnostics and Therapeutics) Market Size by Type (2014-2019) (Million US$)
Table Europe Glycobiology (Diagnostics and Therapeutics) Market Share by Type (2014-2019)
Table Europe Glycobiology (Diagnostics and Therapeutics) Market Size by Application (2014-2019) (Million US$)
Table Europe Glycobiology (Diagnostics and Therapeutics) Market Share by Application (2014-2019)
Figure China Glycobiology (Diagnostics and Therapeutics) Market Size 2014-2019 (Million US$)
Table China Key Players Glycobiology (Diagnostics and Therapeutics) Revenue (2018-2019) (Million US$)
Table China Key Players Glycobiology (Diagnostics and Therapeutics) Market Share (2018-2019)
Table China Glycobiology (Diagnostics and Therapeutics) Market Size by Type (2014-20189) (Million US$)
Table China Glycobiology (Diagnostics and Therapeutics) Market Share by Type (2014-2019)
Table China Glycobiology (Diagnostics and Therapeutics) Market Size by Application (2014-2019) (Million US$)
Table China Glycobiology (Diagnostics and Therapeutics) Market Share by Application (2014-2019)
Figure Japan Glycobiology (Diagnostics and Therapeutics) Market Size 2014-2019 (Million US$)
Table Japan Key Players Glycobiology (Diagnostics and Therapeutics) Revenue (2018-2019) (Million US$)
Table Japan Key Players Glycobiology (Diagnostics and Therapeutics) Market Share (2018-2019)
Table Japan Glycobiology (Diagnostics and Therapeutics) Market Size by Type (2014-2019) (Million US$)
Table Japan Glycobiology (Diagnostics and Therapeutics) Market Share by Type (2014-2019)
Table Japan Glycobiology (Diagnostics and Therapeutics) Market Size by Application (2014-2019) (Million US$)
Table Japan Glycobiology (Diagnostics and Therapeutics) Market Share by Application (2014-2019)
Figure Southeast Asia Glycobiology (Diagnostics and Therapeutics) Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Glycobiology (Diagnostics and Therapeutics) Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Glycobiology (Diagnostics and Therapeutics) Market Share (2018-2019)
Table Southeast Asia Glycobiology (Diagnostics and Therapeutics) Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Glycobiology (Diagnostics and Therapeutics) Market Share by Type (2014-2019)
Table Southeast Asia Glycobiology (Diagnostics and Therapeutics) Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Glycobiology (Diagnostics and Therapeutics) Market Share by Application (2014-2019)
Figure India Glycobiology (Diagnostics and Therapeutics) Market Size 2014-2019 (Million US$)
Table India Key Players Glycobiology (Diagnostics and Therapeutics) Revenue (2018-2019) (Million US$)
Table India Key Players Glycobiology (Diagnostics and Therapeutics) Market Share (2018-2019)
Table India Glycobiology (Diagnostics and Therapeutics) Market Size by Type (2014-2019) (Million US$)
Table India Glycobiology (Diagnostics and Therapeutics) Market Share by Type (2014-2019)
Table India Glycobiology (Diagnostics and Therapeutics) Market Size by Application (2014-2019) (Million US$)
Table India Glycobiology (Diagnostics and Therapeutics) Market Share by Application (2014-2019)
Figure Central & South America Glycobiology (Diagnostics and Therapeutics) Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Glycobiology (Diagnostics and Therapeutics) Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Glycobiology (Diagnostics and Therapeutics) Market Share (2018-2019)
Table Central & South America Glycobiology (Diagnostics and Therapeutics) Market Size by Type (2014-2019) (Million US$)
Table Central & South America Glycobiology (Diagnostics and Therapeutics) Market Share by Type (2014-2019)
Table Central & South America Glycobiology (Diagnostics and Therapeutics) Market Size by Application (2014-2019) (Million US$)
Table Central & South America Glycobiology (Diagnostics and Therapeutics) Market Share by Application (2014-2019)
Table Biomarin Pharmaceutical Inc. Company Details
Table Biomarin Pharmaceutical Inc. Revenue in Glycobiology (Diagnostics and Therapeutics) Business (2014-2019) (Million US$)
Figure Biomarin Pharmaceutical Inc. Revenue Growth Rate in Glycobiology (Diagnostics and Therapeutics) Business (2014-2019)
Table Biomarin Pharmaceutical Inc. Recent Development
Table Glycomimetics Company Details
Table Glycomimetics Revenue in Glycobiology (Diagnostics and Therapeutics) Business (2014-2019)(Million US$)
Figure Glycomimetics Revenue Growth Rate in Glycobiology (Diagnostics and Therapeutics) Business (2014-2019)
Table Glycomimetics Recent Development
Table Glycan Biosciences Llc Company Details
Table Glycan Biosciences Llc Revenue in Glycobiology (Diagnostics and Therapeutics) Business (2014-2019)(Million US$)
Figure Glycan Biosciences Llc Revenue Growth Rate in Glycobiology (Diagnostics and Therapeutics) Business (2014-2019)
Table Glycan Biosciences Llc Recent Development
Table Glycosensors And Diagnostics Llc Company Details
Table Glycosensors And Diagnostics Llc Revenue in Glycobiology (Diagnostics and Therapeutics) Business (2014-2019)(Million US$)
Figure Glycosensors And Diagnostics Llc Revenue Growth Rate in Glycobiology (Diagnostics and Therapeutics) Business (2014-2019)
Table Glycosensors And Diagnostics Llc Recent Development
Table Glycotest Inc. Company Details
Table Glycotest Inc. Revenue in Glycobiology (Diagnostics and Therapeutics) Business (2014-2019)(Million US$)
Figure Glycotest Inc. Revenue Growth Rate in Glycobiology (Diagnostics and Therapeutics) Business (2014-2019)
Table Glycotest Inc. Recent Development
Table Global Glycobiology (Diagnostics and Therapeutics) Market Size by Regions (Million US$) 2019-2025
Figure Global Glycobiology (Diagnostics and Therapeutics) Market Size Share by Regions (2019-2025)
Figure Global Glycobiology (Diagnostics and Therapeutics) Market Size Share by Regions in 2025
Figure United States Glycobiology (Diagnostics and Therapeutics) Market Size Forecast (2019-2025)(Million USD)
Figure Europe Glycobiology (Diagnostics and Therapeutics) Market Size Forecast (2019-2025)(Million USD)
Figure China Glycobiology (Diagnostics and Therapeutics) Market Size Forecast (2019-2025)(Million USD)
Figure Japan Glycobiology (Diagnostics and Therapeutics) Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Glycobiology (Diagnostics and Therapeutics) Market Size Forecast (2019-2025)(Million USD)
Figure India Glycobiology (Diagnostics and Therapeutics) Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Glycobiology (Diagnostics and Therapeutics) Market Size Forecast (2019-2025)(Million USD)
Table Global Glycobiology (Diagnostics and Therapeutics) Market Size by Product (2019-2025) (Million US$)
Figure Global Glycobiology (Diagnostics and Therapeutics) Market Size by Product (2019-2025)
Figure Global Glycobiology (Diagnostics and Therapeutics) Market Size by Product in 2025
Table Global Glycobiology (Diagnostics and Therapeutics) Market Size by Application (2019-2025) (Million US$)
Figure Global Glycobiology (Diagnostics and Therapeutics) Market Size by Application (2019-2025)
Figure Global Glycobiology (Diagnostics and Therapeutics) Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界のエキソソーム診断と治療学市場：市場規模・現状・予測 Exosomes play a key role in facilitating cell-to-cell communication in the cancer prognosis. It suppresses the immune function by inducing apoptosis of activated cytotoxic T cells, which enable tumor progression in the human body.In 2018, the global Exosome Diagnostics and Therapeutics market size w…- 世界のグリコミクス/糖鎖生物学市場：市場規模・現状・予測 Glycomics is the comprehensive study of glycomes (the entire complement of sugars, whether free or present in more complex molecules of an organism), including genetic, physiologic, pathologic, and other aspects. Glycomics "is the systematic study of all glycan structures of a given cell type or org…
- 世界の非侵襲的がん診断市場：市場規模・現状・予測 Non-invasive diagnosis is a procedure of identifying a disease without or with minimal incision of the body. These methods involve different techniques such as identifying genetic structure, biomarkers, changes in molecular biology, along with imaging technologies. Cancer is a disease related to gen…
- 世界の院内感染診断市場：市場規模・現状・予測 In 2018, the global Hospital-acquired Infection Diagnostics market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Hospital-acquired Infection Diagnostics status, future forecast, growth opportunity, …
- 世界の肺がんの診断市場：市場規模・現状・予測 Diagnosis of lung cancer depends on lung histology or sputum shedding cytology. Screening methods for lung cancer mainly include X-ray chest X-ray and sputum cytology, low-dose spiral CT, blood and sputum biomarkers, and exhalation gas monitoring.As people's awareness of cancer increases and technol…